Nuclear Medicine Clinic Launches Most Effective Technique to Diagnose Neuroendocrine Tumors

From October 2019, the most effective molecular imaging diagnostics of neuroendocrine tumours is also available at the UMC Ljubljana. At the Clinic for Nuclear Medicine, a PET/CT scanning, using the gallium-68 (68Ga) labelled somatostatin analogue ([68Ga] Ga-DOTA-TATE), was conducted for the first time in Slovenia.

The examination is intended to determine the presence and prevalence of neuroendocrine tumours and to monitor the efficacy of treatment.

The [68Ga] Ga-DOTA-TATE PET/CT scan has a significantly higher sensitivity than all diagnostic tests used so far, and by now, this demanding examination technique has only been possible in few centres abroad. The examination is based on a technologically advanced process using advanced analytical technology that provides adequate quality of the radiopharmaceutical [68Ga] Ga-DOTA-TATE for clinical use. With the introduction of a PET/CT scanning with [68Ga] Ga-DOTA-TATE, referrals of Slovenian patients abroad are no longer required. Slovenian patients and physicians have now the best examination technique to diagnose neuroendocrine tumours.

Members of the Medial Physiscs resarch group – Petra Kolenc Peitl, Luka Ležaić and Katja Zaletel – participated in the launch of the investigation.

More information can be found on the UMC Ljubljana website